To identifysuitable cancer cell lines for testing the binding affinity of LNPsmodified with AKPC, we measured CD44 expression levels in differentbreast and prostate tumor cells by Western blotting (WB) (Figure 2a,b). The gene discussed is CD44; the disease is prostate neoplasm.